Lords Mark Industries (LMIL) has achieved a defining milestone in India's med-tech landscape by receiving the licence to ...
This achievement becomes even more historic as LMIL–Renalyx has now received the globally recognised CE marking, making it ...
Lords Mark Industries–Renalyx earns India’s Class C licence and CE certification to build the world’s first AI-based smart hemodialysis machines, advancing med-tech innovation.
Securing a licence to manufacture Class C World’s First AI-Based Smart Hemodialysis Machines is one of the toughest ...
India’s largest dialysis chain is leaning on higher-priced global markets to lift margins. But rising complexity, staffing ...
Lords Mark Industries Ltd. (LMIL) has achieved a defining milestone in India's med-tech landscape by receiving the licence to ...
Nephrocare Health IPO opens on December 10, 2025, aiming to raise ₹871.05 crore with a price band of ₹438 to ₹460 per share.
Lord’s Mark Industries acquires an 85% stake in Renalyx to scale AI-enabled indigenous dialysis technology, strengthen Make ...
The dialysis market is expected to grow at a compound annual growth rate (CAGR) of around 8% during the forecast period. This growth is primarily fueled by the rising prevalence of chronic kidney ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Climate change isn’t just altering weather patterns; it’s reshaping disease. Among its most ...